Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare
Leading healthcare company focused on developing treatments for chronic diseases leverages Deal Box's capital raise technology for growth funding round
The global healthcare and life sciences industry is expected to hit
With a commitment to improve healthcare outcomes, Biostax is focused on driving the development and commercialization of proprietary mechanisms, like pharmaceutical, biotechnology, and MedTech products to prevent, intercept, and improve autoimmune and chronic illnesses. The company's objective directly aligns with Deal Box's mission to invest in innovative companies looking to improve the world. Deal Box's capital raise technology will streamline Biostax's access to a wider range of investors and secure funding more efficiently to not only provide affordable healthcare to those with autoimmune and chronic illnesses, but also diversify their reach to other critical areas.
"Biostax brings innovative technology and commitment to expansion to the table, as well as, aiming to provide medical care to those with little access, which will certainly bring forth immense value to investors," said Thomas Carter, CEO and Chairman of Deal Box. "Biostax is fixated on refining what affordable health care means to society, and we are excited to support them through this growth capital round."
"We are thrilled for the launch of our growth funding round, and even more so to have Deal Box alongside us. Deal Box is not only just as committed to our mission as we are, but also dedicated to advising and guiding our company during a time of tremendous growth and expansion into a growing market with vast potential" said Kelly Wilson, CEO of Biostax. "The Deal Box platform is forthright and efficient, preventing us from wasting time with uninterested investors and leading us towards raising more capital with meaningful investors that see value in our mission to reinvent access to affordable health care."
To learn more about Deal Box and its investment packaging services, visit here. You can also click here to learn more about Biostax and their innovative approach to affordable healthcare.
About Deal Box
Deal Box is a digital assets platform transforming venture investments. Since 2017, Deal Box has rigorously vetted and digitized over
About Biostax
Biostax Corp. is a pioneering pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and biotechnology products that have a well-defined path to market. By utilizing a biotech portfolio hub-and-spoke engine, the company plans to advance focused and efficient small-scale biotechnology and pharmaceutical programs through subsidiaries, investment vehicles, or partnerships, and deploy its products from those programs in markets both in the
For Media Enquiries
Sena McGrand/Michael Gallo
Lumina Communications
Dealbox@luminapr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biostax-launches-growth-funding-round-to-revitalize-affordable-healthcare-301835857.html
SOURCE Deal Box